Furthermore, most of the CD4+ EM cells could be identified as CCR5-expressing Th1 cells in a subgroup of patients analyzed by a second antibody panel (Supplementary Figure S5), which are known to be primarily responsible for disease progression in LN (30–32). Here, CD4 is linked to lobular neoplasia.